Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
B
B

BayerAG


Balita

Bayer: Receives Breakthrough Therapy Designation In China For Bay 2927088 In High Unmet Need Patients With Her2-Mutant Non-Small Cell Lung Cancer

BRIEF-Bayer: Receives Breakthrough Therapy Designation In China For Bay 2927088 In High Unmet Need Patients With Her2-Mutant Non-Small Cell Lung Cancer June 11 (Reuters) - Bayer AG BAYGn.DE : RECEIVES BREAKTHROUGH THERAPY DESIGNATION IN CHINA FOR BAY 2927088 IN HIGH UNMET NEED PATIENTS WITH HER2-MUTANT NON-SMALL CELL LUNG CANCER Further company cov
B

Asmi, Beiersdorf, SSE

EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Asmi, Beiersdorf and SSE, on Friday. HIGHLIGHTS * Arcadis NV ARDS.AS : KBC Securities raises to accumulate from buy * Asmi ASMI.AS : Berenberg raises target price to EUR 720 from EUR 640 * Beiersdorf BEIG.DE : HSBC raises target price to EUR 158 from EUR 152 * Nibe Industrier AB NIBEB.ST : HSBC cuts to hold from buy * SSE SSE.L : HS
A
B
B
C
D
E
E
I
J
L
L
S
W

Asmi, Beiersdorf, SSE

CORRECTED-EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE Corrects Greenyard NV entry to say KBC Securities raises target price to EUR 9.5 from EUR 8.5 (not 6.30) and Arcadis NV entry to say KBC Securities cuts (not raises) to 'accumulate' from 'buy'; raises target price to EUR 66 from EUR 61 (not 61.7 June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Asmi, Beiersdorf and SSE, on Friday.
A
B
B
B
C
D
D
E
E
I
J
K
L
L
P
R
S
V
V
V
W
P
S

Motor racing-F1 teams harnessing AI for speed and strategy

Motor racing-F1 teams harnessing AI for speed and strategy By Alan Baldwin June 6 (Reuters) - Formula One has a generative AI-designed trophy at the Canadian Grand Prix but, novelty and sponsorship aside, the importance of artificial intelligence for speed and strategy is growing stronger all the time. The various software systems are helping cars go faster and teams become more competitive, crunching terabytes of data to analyse simulations and cut the time it takes to get parts to the racetrac
A
B

Health Rounds: Untreated atrial fibrillation can raise risk of dementia, death

Health Rounds: Untreated atrial fibrillation can raise risk of dementia, death Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here . By Nancy Lapid June 6(Reuters) - Hello Health Rounds Readers! Today we share some important findings for people with the common heart rhythm disorder atrial fibrillation: taking blood thinners that reduce the risk of strokes may also stave off a form
B
P

Bayer rises after judge cuts Roundup verdict

BUZZ-Bayer rises after judge cuts Roundup verdict ** Shares in Bayer BAYGn.DE are up 2.7% in early Frankfurt trade after a Pennsylvania judge slashed a $2.25 billion U.S. verdict against the German firm to $400 million ** "BAYN shares should react positive on story this morning but damages for Bayer are still too high to get relaxed," a local trade
B

Judge cuts Bayer $2.25 billion Roundup verdict to $400 million

UPDATE 2-Judge cuts Bayer $2.25 billion Roundup verdict to $400 million Adds statistic about Bayer's recent win-loss record paragraph 11 By Dietrich Knauth NEW YORK, June 4 (Reuters) - A Pennsylvania judge on Tuesday slashed a $2.25 billion U.S. verdict against Bayer BAYGn.DE to $400 million for a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller.
B

Judge cuts Bayer $2.25 billion Roundup verdict to $400 million

Judge cuts Bayer $2.25 billion Roundup verdict to $400 million By Dietrich Knauth NEW YORK, June 4 (Reuters) - A Pennsylvania judge on Tuesday slashed a $2.25 billion U.S. verdict against Bayer BAYGn.DE to $400 million for a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller. A jury in the Philadelphia Court of Common Pleas found that John McKivison's non-Hodgkins lymphoma was the result of using Roundup for yard work at his house for several years, a
B

US judicial panel approves rule governing federal mass torts

US judicial panel approves rule governing federal mass torts By Nate Raymond June 4 (Reuters) - A U.S. judicial panel on Tuesday approved the first-ever rule designed to govern federal mass torts cases and provide judges an initial roadmap to follow when assigned to hear hundreds or thousands of lawsuits against companies. The U.S. Judicial Conference's Committee on Rules of Practice and Procedure during a meeting in Washington, D.C., voted in favor of a rule that would give judges guidance on h
B

Bayer Announces A Strategic Collaboration With Samsung Electronics America, Inc.

BRIEF-Bayer Announces A Strategic Collaboration With Samsung Electronics America, Inc. June 3 (Reuters) - BAYER AG BAYGn.DE : BAYER AG - BAYER AG TODAY ANNOUNCED A STRATEGIC COLLABORATION WITH SAMSUNG ELECTRONICS AMERICA, INC. COMPANIES WILL CO-DEVELOP AN OBSERVATIONAL STUDY TO FURTHER IMPROVE UNDERSTANDING OF BURDEN AND IMPACT OF SDM USING DATA PROVIDED BY WOMEN THROUGH SAMSUNG CONSUMER DEVICES.
B

Currys, Ovhcloud, Whitbread

EUROPE RESEARCH ROUNDUP-Currys, Ovhcloud, Whitbread May 30 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Currys, Ovhcloud and Whitbread, on Thursday. HIGHLIGHTS * Anglo American AAL.L : Jefferies cuts to hold from buy * Currys Plc CURY.L : Berenberg raises to buy from hold * Ovhcloud OVH.PA : Stifel cuts to hold from buy * Solvay SOLB.BR : Morgan Stanley raises to equal weight from underweight * Whitbread WTB.L : Berenberg cuts t
A
A
B
B
E
F
G
K
L
L
M
M
N
P
R
S
W
W
H
A
A
A
M

Health Rounds: Experimental treatment slows advanced colon cancer, improves survival in trial

Health Rounds: Experimental treatment slows advanced colon cancer, improves survival in trial Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here . By Nancy Lapid May 28 (Reuters) - Hello Health Rounds Readers! Today we highlight another study to be presented at the year's most important oncology meeting this weekend, a combination therapy that slowed progression and improved surv
B

Motor racing-RB happy with Tsunoda and Ricciardo, says Bayer

Motor racing-RB happy with Tsunoda and Ricciardo, says Bayer By Alan Baldwin MONACO, May 24 (Reuters) - Yuki Tsunoda has made a big step up this season and RB would be keen for the Japanese to stay next year, the Red Bull-owned team's chief executive Peter Bayer said on Friday. The Honda-backed driver's place has looked uncertain with the manufacturer moving to Aston Martin for 2026, when Formula One starts a new engine era.
B

India economic, corporate events on May 23

DIARY- India economic, corporate events on May 23 BENGALURU, May 23 (Reuters) - Diary of India economic, corporate events on May 23. ECONOMIC, CORPORATE .BSE500 EVENTS: RIC Local Start Date Local Time Indicator Name Period Reuters Poll Prior INPMSF=ECI 23 May 2024 10:30 HSBC Services Flash PMI May 61.1 60.8 INPMCF=ECI 23 May 2024 10:30 HSBC Composi
B
H

Iberdrola And Bayer Sign Off-Site PPA For Clean Energy Supply In Italy

BRIEF-Iberdrola And Bayer Sign Off-Site PPA For Clean Energy Supply In Italy May 22 (Reuters) - Iberdrola SA IBE.MC : SIGNS WITH BAYER OFF-SITE PPA FOR SUPPLY OF CLEAN ENERGY IN ITALY WITH A DURATION OF 11 YEARS, THE PPA CONTEMPLATES A TOTAL OF 33 GWH OVER THE ENTIRE PERIOD. Further company coverage: IBE.MC (Gdansk Newsroom)
B

Bayer AG Says Elinzanetant Significantly Reduces Frequency And Severity Of Moderate To Severe Hot Flashes Associated With Menopause

BRIEF-Bayer AG Says Elinzanetant Significantly Reduces Frequency And Severity Of Moderate To Severe Hot Flashes Associated With Menopause May 16 (Reuters) - Bayer AG BAYGn.DE : ELINZANETANT SIGNIFICANTLY REDUCES FREQUENCY AND SEVERITY OF MODERATE TO SEVERE HOT FLASHES ASSOCIATED WITH MENOPAUSE ELINZANETANT SUCCESSFULLY MET ALL FOUR PRIMARY ENDPOINT
B

Ag inputs sales seen at good level in the US, not as good in South America

Ag inputs sales seen at good level in the US, not as good in South America By Marcelo Teixeira NEW YORK, May 16 (Reuters) - Sales of agricultural inputs such as fertilizers and crop care products have been near normal in the United States despite lower grain prices, while they are not as good in South America, according to agricultural input producers.
B
C

Bayer AG: Starts Phase I Study With 225Ac-Psma-Trillium In Advanced Metastatic Prostate Cancer

BRIEF-Bayer AG: Starts Phase I Study With 225Ac-Psma-Trillium In Advanced Metastatic Prostate Cancer May 15 (Reuters) - Bayer AG BAYGn.DE : STARTS PHASE I STUDY WITH NOVEL TARGETED RADIONUCLIDE THERAPY 225AC-PSMA-TRILLIUM IN ADVANCED METASTATIC PROSTATE CANCER Source text for Eikon: [ID:] Further company coverage: BAYGn.DE Reporting by Berlin Newsr
B

Europe eyes flat start, eyes on corporate Germany

LIVE MARKETS-Europe eyes flat start, eyes on corporate Germany Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EUROPE EYES FLAT START, EYES ON CORPORATE GERMANY Shares in Europe were set for another muted session on Tuesday, with futures stuck around parity, as traders sat on the sidelines ahead of U.S.
B
B
P
R
V
V
A
U

Bayer's first-quarter adjusted profit falls less than expected

UPDATE 2-Bayer's first-quarter adjusted profit falls less than expected Recasts, adds details, background on job cuts from paragraph 11 By Ludwig Burger FRANKFURT, May 14 (Reuters) - Bayer BAYGn.DE beat first-quarter analyst forecasts as it reported a slight drop in adjusted earnings on Tuesday, providing a respite for the CEO's turnaround efforts.
B



Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.